L’anticorps anti-NAPSA Polyclonal Lapin est utilisé pour la détection de NAPSA dans des échantillons de Humain et Souris. Il a été validé pour IHC, ELISA et IF.
NAPSA
Reactivité: Humain, Rat, Lapin
IHC, WB
Hôte: Lapin
Monoclonal
NAPSA-1865R
unconjugated
Recombinant Antibody
Indications d'application
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:50-200,ELISA 1:10000-20000,IF 1:50-200
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Date de péremption
12 months
Antigène
NAPSA
(Napsin A Aspartic Peptidase (NAPSA))
Autre désignation
Napsin A
Sujet
Napsin-A, Aspartyl protease 4, ASP4, Asp 4, Napsin-1, TA01/TA02NAPSA encodes a member of the peptidase A1 family of aspartic proteases. The encoded preproprotein is proteolytically processed to generate an activation peptide and the mature protease. The activation peptides of aspartic proteinases function as inhibitors of the protease active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The encoded protease may play a role in the proteolytic processing of pulmonary surfactant protein B in the lung and may function in protein catabolism in the renal proximal tubules. NAPSA has been described as a marker for lung adenocarcinoma and renal cell carcinoma.